Follow
Abhishek Shinghal
Abhishek Shinghal
Assistant Professor, Tata Memorial Centre, Varanasi
Verified email at mpmmcc.tmc.gov.in
Title
Cited by
Cited by
Year
Effect of COVID-19 pandemic on gynecological cancer radiation during complete nationwide lockdown: observations and reflections from tertiary care institute in India
A Shinghal, S Paul, S Chopra, L Gurram, L Scaria, S Kohle, P Rane, ...
Advances in Radiation Oncology 6 (6), 100725, 2021
102021
Is FAST FORWARD the Way Forward in Radiotherapy for Locally Advanced Breast Cancer–Learnings From the COVID Pandemic
P Giridhar, S Pradhan, L Pujari, P Singh, A Shinghal, C Khandelwal, ...
Clinical Breast Cancer 24 (3), e116-e125, 2024
12024
Oncology: Radiation Oncologist’s View
S Pradhan, A Mukherjee, V Saini, G HB, AR Kapoor, A Shinghal, L Pujari, ...
Cancer Diagnostics and Therapeutics: Current Trends, Challenges, and Future …, 2022
12022
Overall survival outcomes of phase II GECCOR-GB trial, a multicentre trial of adjuvant adjuvant gemcitabine plus cisplatin (GC) and capecitabine with concurrent capecitabine …
PG BHARGAVA, S Patkar, VS Ostwal, R Engineer, M Parulekar, ...
Journal of Clinical Oncology 42 (16_suppl), 4124-4124, 2024
2024
A multicenter, open-label, randomized phase II study evaluating adjuvant gemcitabine plus cisplatin (GC) and capecitabine with concurrent capecitabine radiotherapy (CAPE-RT) in …
A Ramaswamy, VS Ostwal, R Engineer, M Parulekar, S Mandavkar, ...
Journal of Clinical Oncology 41 (16_suppl), 4017-4017, 2023
2023
PO-1287 real world experience with extreme hypofractionated breast RT in a tertiary care center in India
L Pujari, A Shinghal, A Mukherji, S Pradhan
Radiotherapy and Oncology 182, S1030-S1031, 2023
2023
Sigmoid dose accumulation and reporting for multifractionated brachytherapy for cervical cancer: Methodological development of sigmoid points through virtual endoscopic method
A Bindal, P Mittal, A Shinghal, L Scaria, K Prajapati, J Swamidas, ...
Brachytherapy 22 (3), 325-333, 2023
2023
Can dysphagia aspiration related structures (DARS) be spared in patients with oropharyngeal cancers? Dosimetric evaluation in a prospective study of DARS optimized intensity …
A Calcuttawala, A Shinghal, AN Budrukkar, M Swain, V Murthy, SG Laskar, ...
Journal of Cancer Research and Therapeutics, 10.4103, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–8